AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Leone, G Sears, R Huang, E Rempel, R Nuckolls, F Park, CH Giangrande, P Wu, LZ Saavedra, HI Field, SJ Thompson, MA Yang, HD Fujiwara, Y Greenberg, ME Orkin, S Smith, C Nevins, JR
Citation: G. Leone et al., Myc requires distinct E2F activities to induce S phase and apoptosis, MOL CELL, 8(1), 2001, pp. 105-113

Authors: Robinson, K Giangrande, P
Citation: K. Robinson et P. Giangrande, Menorrhagia - Underlying bleeding disorders need to be ruled out, BR MED J, 322(7288), 2001, pp. 732-732

Authors: Wu, LZ Timmers, C Maiti, B Saavedra, HI Sang, L Chong, GT Nuckolls, F Giangrande, P Wright, FA Field, SJ Greenberg, ME Orkin, S Nevins, JR Robinson, ML Leone, G
Citation: Lz. Wu et al., The E2F1-3 transcription factors are essential for cellular proliferation, NATURE, 414(6862), 2001, pp. 457-462

Authors: Babiker, A Darby, S De Angelis, D Kwart, D Porter, K Beral, V Darbyshire, J Day, N Gill, N Coutinho, R Prins, M van Benthem, B Coutinho, R Dabis, F Marimoutou, C Ruiz, I Tusell, J Altisent, C Evatt, B Jaffe, H Kirk, O Pedersen, C Rosenberg, P Goedert, J Biggar, R Melbye, M Brettie, R Downs, A Hamouda, O Touloumi, G Karafoulidou, A Katsarou, O Donfield, S Gomperts, E Hilgartner, M Hoots, K Schoenbaum, E Beral, V Zangerle, R Del Amo, J Pezzotti, P Rezza, G Hutchinson, S Day, N De Angelis, D Gore, S Kingsley, L Schrager, L Rosenberg, P Goedert, J Melnick, S Koblin, B Eskild, A Bruun, J Sannes, M Evans, B Lepri, AC Sabin, C Buchbinder, S Vittinghoff, E Moss, A Osmond, D Winkelstein, W Goldberg, D Boufassa, F Meyer, L Egger, M Francioli, P Rickenbach, M Cooper, D Tindall, B Sharkey, T Vizzard, J Kaldor, J Cunningham, P Vanhems, P Vizzard, J Kaldor, J Learmont, J Farewell, V Berglund, O Mosley, J Operskalski, E van den Berg, M Metzger, D Tobin, D Woody, G Rusnak, J Hendrix, C Garner, R Hawkes, C Renzullo, P Garland, F Darby, S Ewart, D Giangrande, P Lee, C Phillips, A Spooner, R Wilde, J Winter, M Babiker, A Darbyshire, J Evans, B Gill, N Johnson, A Phillips, A Porter, K Lorenzo, JI Schechter, M
Citation: A. Babiker et al., Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis, LANCET, 355(9210), 2000, pp. 1131-1137

Authors: Baker, P Clarke, K Giangrande, P Keeling, D
Citation: P. Baker et al., Ala-10 mutations in the factor IX propeptide and haemorrhage in a patient treated with warfarin, BR J HAEM, 108(3), 2000, pp. 663-663

Authors: Lee, CA Owens, D Bray, G Giangrande, P Collins, P Hay, C Gomperts, E Schroth, P Barrowcliffe, T
Citation: Ca. Lee et al., Pharmacokinetics of recombinant factor VIII (recombinate) using one-stage clotting and chromogenic factor VIII assay, THROMB HAEM, 82(6), 1999, pp. 1644-1647

Authors: Wagner, BL Pollio, G Giangrande, P Webster, JC Breslin, M Mais, DE Cook, CE Vedeckis, WV Cidlowski, JA McDonnell, DP
Citation: Bl. Wagner et al., The novel progesterone receptor antagonists RTI 3021-012 and RTI 3021-022 exhibit complex glucocorticoid receptor antagonist activities: Implicationsfor the development of dissociated antiprogestins, ENDOCRINOL, 140(3), 1999, pp. 1449-1458

Authors: Lee, CA Ironside, JW Bell, JE Giangrande, P Ludlam, C Esiri, MM McLaughlin, JE
Citation: Ca. Lee et al., Retrospective neuropathological review of prion disease in UK haemophilic patients, THROMB HAEM, 80(6), 1998, pp. 909-911
Risultati: 1-8 |